▲ +170.42% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Repro Med Systems in the last 3 months. The average price target is $8.17, with a high forecast of $16.00 and a low forecast of $3.50. The average price target represents a 170.42% upside from the last price of $3.02.
The current consensus among 3 contributing investment analysts is to hold stock in Repro Med Systems.
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.